Terms: = Brain cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1 AND Treatment
3 results:
1. Cost‑Effectiveness of Lorlatinib in First-Line treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung cancer in Sweden.
Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
[TBL] [Abstract] [Full Text] [Related]
2. ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via mek4/MAPK pathway.
Cai L; Wu ZR; Cao L; Xu JD; Lu JL; Wang CD; Jin JH; Wu ZB; Su ZP
Acta Pharmacol Sin; 2022 Sep; 43(9):2386-2396. PubMed ID: 35082393
[TBL] [Abstract] [Full Text] [Related]
3. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract] [Full Text] [Related]
